These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9359490

  • 21. Anti-estrogens enhance the therapeutic effect of lymphokine-activated killer cells on the P815 murine mastocytoma.
    Baral E, Nagy E, Kangas L, Berczi I.
    Int J Cancer; 1996 Aug 07; 67(4):580-5. PubMed ID: 8759619
    [Abstract] [Full Text] [Related]

  • 22. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW, Leu NR, Shannon BJ, Fast DJ.
    J Immunol; 1991 Sep 15; 147(6):1816-22. PubMed ID: 1909732
    [Abstract] [Full Text] [Related]

  • 23. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL, Boon T.
    Eur J Immunol; 1982 May 15; 12(5):406-12. PubMed ID: 6178608
    [Abstract] [Full Text] [Related]

  • 24. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules.
    Greene AL, Makrigiannis AP, Fitzpatrick L, Hoskin DW.
    J Interferon Cytokine Res; 1997 Dec 15; 17(12):727-37. PubMed ID: 9452360
    [Abstract] [Full Text] [Related]

  • 25. Regulatory role of CD8 in major histocompatibility complex-unrestricted tumoricidal activity of mouse T cells activated with anti-CD3 monoclonal antibody.
    Stewart BH, Hoskin DW.
    Immunol Invest; 1997 Dec 15; 26(5-7):601-14. PubMed ID: 9399103
    [Abstract] [Full Text] [Related]

  • 26. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
    Uslu R, Jewett A, Bonavida B.
    Gynecol Oncol; 1996 Aug 15; 62(2):282-91. PubMed ID: 8751562
    [Abstract] [Full Text] [Related]

  • 27. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ.
    J Immunol; 2002 Apr 01; 168(7):3484-92. PubMed ID: 11907109
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ, Butterfield LH, Dissette VB, Economou JS, Bonavida B.
    J Immunol; 2001 Mar 01; 166(5):3564-73. PubMed ID: 11207317
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cisplatin induces fas expression in esophageal cancer cell lines and enhanced cytotoxicity in combination with LAK cells.
    Matsuzaki I, Suzuki H, Kitamura M, Minamiya Y, Kawai H, Ogawa J.
    Oncology; 2000 Nov 01; 59(4):336-43. PubMed ID: 11096347
    [Abstract] [Full Text] [Related]

  • 32. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
    Komada Y, Zhou YW, Zhang XL, Chen TX, Tanaka S, Azuma E, Sakurai M.
    Br J Haematol; 1997 Jan 01; 96(1):147-57. PubMed ID: 9012700
    [Abstract] [Full Text] [Related]

  • 33. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA, Kerkvliet NI.
    J Immunol; 1997 Mar 15; 158(6):2695-703. PubMed ID: 9058803
    [Abstract] [Full Text] [Related]

  • 34. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES.
    J Immunol; 1986 Feb 15; 136(4):1510-5. PubMed ID: 3080526
    [Abstract] [Full Text] [Related]

  • 35. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP, Musgrave BL, Hoskin DW.
    J Leukoc Biol; 1999 Nov 15; 66(5):792-802. PubMed ID: 10577511
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.